Factors Influencing Lower Urinary Tract Symptoms in Advanced Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to investigate the severity of lower urinary tract symptoms (LUTS) and to identify factors that influenced LUTS in advanced cancer patients with chemotherapy-induced peripheral neuropathy (CIPN). Methods: This cross-sectional study included a total of 158 advanced cancer patients with CIPN. A structured questionnaire including the International Prostate Symptom Score and the Functional Assessment of Cancer Therapy/Gynecology Oncology Group/Neurotoxicity scale was used. Data were analyzed using the Pearson correlation coefficient and multiple regression analysis. Results: Nocturia was the most prevalent LUTS. A positive relationship was found between CIPN symptoms and LUTS. The duration of cancer diagnosis and the severity of CIPN were key factors that influenced LUTS. Conclusions: The severity of CIPN symptoms was the most important predictor of LUTS. Nurses’ care for advanced cancer patients should incorporate a comprehensive health assessment, which includes a history of treatment and physical neuropathic symptoms, for any patient complaining of CIPN symptoms.
Abstract
Purpose: This study aimed to investigate the severity of lower urinary tract symptoms (LUTS) and to identify factors that influenced LUTS in advanced cancer patients with chemotherapy-induced peripheral neuropathy (CIPN). Methods: This cross-sectional study included a total of 158 advanced cancer patients with CIPN. A structured questionnaire including the International Prostate Symptom Score and the Functional Assessment of Cancer Therapy/Gynecology Oncology Group/Neurotoxicity scale was used. Data were analyzed using the Pearson correlation coefficient and multiple regression analysis. Results: Nocturia was the most prevalent LUTS. A positive relationship was found between CIPN symptoms and LUTS. The duration of cancer diagnosis and the severity of CIPN were key factors that influenced LUTS. Conclusions: The severity of CIPN symptoms was the most important predictor of LUTS. Nurses’ care for advanced cancer patients should incorporate a comprehensive health assessment, which includes a history of treatment and physical neuropathic symptoms, for any patient complaining of CIPN symptoms.
참고문헌 (29)
- Camps C, "Weekly paclitaxel as second", third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerability, 2005, pp.25(6C), 4611~4614
- Kautio AL, "Burden of chemotherapy-induced neuropathy--a cross-sectional study", Support Care Cancer, 19, pp.1991~1996 (2011)[DOI]
- 유양숙, "Relationship between Quality of Life and Nurse-led Bedside Symptom Evaluations in Patients with Chemotherapy-induced Peripheral Neuropathy", Asian Nursing Research, 8(1), pp.36~41 (2014), 한국간호과학회
- Grisold W, "Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention", Neuro Oncol, 14(Suppl 4), pp.iv45~iv54 (2012)
- Stubblefield MD, "NCCN task force report: management of neuropathy in cancer", J Natl Compr Canc Netw, 7(Suppl 5), pp.S1~S26 (2009)
- Abrams P, "The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society", Neurourol Urodyn, 21, pp.167~178 (2002)[DOI]
- Faithfull S, "Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies", Int J Clin Pract, 69, pp.1184~1208 (2015)[DOI]
- Hsieh CI, "Prevalence, associated factors, and relationship to quality of life of lower urinary tract symptoms: a cross-sectional, questionnaire survey of cancer patients", Int J Clin Pract, 67, pp.566~575 (2013)[DOI]
- Gift AG, "Symptom clusters in elderly patients with lung cancer", Oncol Nurs Forum, 31, pp.202~212 (2004)
- White AJ, "Urinary incontinence and health-related quality of life among older Americans with and without cancer: a cross-sectional study", BMC Cancer, 13, pp.377~ (2013)[DOI]
- Marinkovic SP, "The management of overactive bladder syndrome", BMJ, 344, pp.e2365~ (2012)[DOI]
- Payne H, "Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges", BJU Int, 112, pp.885~897 (2013)
- Lange MM, "Urinary dysfunction after rectal cancer treatment is mainly caused by surgery", Br J Surg, 95, pp.1020~1028 (2008)[DOI]
- Calhoun EA, "Psychometric evaluation of the Functional Assessment of Cancer Therapy", Gynecologic Oncology Group-Neurotoxicity (Fact, Int J Gynecol Cancer, pp.2003, 13[DOI]
- Barry MJ, "The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association", J Urol, 148, pp.1549~1557 (1992)[DOI]
- Choi HR, "Translation validity and reliability of I-PSS Korean Version", Korean J Urol, 37, pp.659~665 (1996)
- Kim NK, "Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer", Dis Colon Rectum, 45, pp.1178~1185 (2002)[DOI]
- Hoskin P, "High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity", Radiother Oncol, 110, pp.268~271 (2014)[DOI]
- Benedetti-Panici P, "Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3-4 radical hysterectomy", Cancer, 100, pp.2110~2117 (2004)[DOI]
- 정호석, "과민성방광 여성에서 나이에 따른 배뇨 형태의 변화", International Neurourology Journal, 13(1), pp.37~44 (2009), 대한배뇨장애요실금학회
- Lee YS, "Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study", World J Urol, 29, pp.185~190 (2011)[DOI]
- Wickham R, "Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice", Clin J Oncol Nurs, 11, pp.361~376 (2007)[DOI]
- 최성호, "후향적 방법을 통한 후각장애환자의 임상적 특성및 Steroid 효과 분석", Journal of Rhinology, 23(1), pp.39~43 (2016), 대한비과학회
- Kupelian V, "Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey", Arch Intern Med, 166, pp.2381~2387 (2006)[DOI]
- Litman HJ, "Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey", Urology, 70, pp.916~921 (2007)[DOI]
- Argyriou AA, "A review on oxaliplatin-induced peripheral nerve damage", Cancer Treat Rev, 34, pp.368~377 (2008)[DOI]
- Windebank AJ, "Chemotherapy-induced neuropathy", J Peripher Nerv Syst, 13, pp.27~46 (2008)[DOI]
- Cavaletti G, "Chemotherapyinduced neuropathy", Curr Treat Options Neurol, 13, pp.180~190 (2011)[DOI]
- Coyne KS, "Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS", BJU Int, 103(Suppl 3), pp.24~32 (2009)
